Comparing concurrent chemoradiotherapy, 125I seed implantation combined with chemotherapy, and chemotherapy alone efficacy in treating unresectable locally advanced pancreatic cancer

Comparing concurrent chemoradiotherapy, 125I seed implantation combined with chemotherapy, and chemotherapy alone efficacy in treating unresectable locally advanced pancreatic cancer

Abstract Background The prognosis for unresectable locally advanced pancreatic cancer (LAPC) is still poor, and the best therapeutic option is still unknown. The common treatments for LAPC, concurrent chemoradiotherapy (CCRT), 125I seed implantation combined with chemotherapy (125IC), and chemothera...

Full description

Bibliographic Details
Main Authors: Yanfen Zheng, Rui Huang, Wenxue Zou, Chao Liu, Hongxin Niu, Jinbo Yue
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Precision Radiation Oncology
Subjects:
chemoradiotherapy
chemotherapy
125I seed implantation
radiation dose
survival rate
unresectable locally advanced pancreatic cancer
Online Access:https://doi.org/10.1002/pro6.1156

Internet

https://doi.org/10.1002/pro6.1156

Similar Items